UA75345C2 - Pharmaceutical composition for topical use intended for treating sebaceous gland disorders and methods of treating acnes using this composition - Google Patents

Pharmaceutical composition for topical use intended for treating sebaceous gland disorders and methods of treating acnes using this composition Download PDF

Info

Publication number
UA75345C2
UA75345C2 UA2002076160A UA2002076160A UA75345C2 UA 75345 C2 UA75345 C2 UA 75345C2 UA 2002076160 A UA2002076160 A UA 2002076160A UA 2002076160 A UA2002076160 A UA 2002076160A UA 75345 C2 UA75345 C2 UA 75345C2
Authority
UA
Ukraine
Prior art keywords
acne
phenyl
differs
disorder
acetyl
Prior art date
Application number
UA2002076160A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of UA75345C2 publication Critical patent/UA75345C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
UA2002076160A 2000-02-02 2001-01-23 Pharmaceutical composition for topical use intended for treating sebaceous gland disorders and methods of treating acnes using this composition UA75345C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17977800P 2000-02-02 2000-02-02
PCT/US2001/002190 WO2001056556A2 (en) 2000-02-02 2001-01-23 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders

Publications (1)

Publication Number Publication Date
UA75345C2 true UA75345C2 (en) 2006-04-17

Family

ID=22657957

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002076160A UA75345C2 (en) 2000-02-02 2001-01-23 Pharmaceutical composition for topical use intended for treating sebaceous gland disorders and methods of treating acnes using this composition

Country Status (34)

Country Link
US (2) US6730703B2 (de)
EP (1) EP1263421B1 (de)
JP (1) JP2003531113A (de)
KR (1) KR20020073574A (de)
CN (1) CN1398182A (de)
AP (1) AP2002002612A0 (de)
AT (1) ATE295724T1 (de)
AU (1) AU781563B2 (de)
BG (1) BG107042A (de)
BR (1) BR0107954A (de)
CA (1) CA2398219A1 (de)
CR (1) CR6712A (de)
DE (1) DE60110897T2 (de)
DZ (1) DZ3288A1 (de)
EA (1) EA004255B1 (de)
EE (1) EE200200429A (de)
ES (1) ES2239145T3 (de)
GE (1) GEP20043286B (de)
HR (1) HRP20020717A2 (de)
HU (1) HUP0301010A3 (de)
IL (1) IL150865A0 (de)
IS (1) IS6478A (de)
MA (1) MA26872A1 (de)
MX (1) MXPA02007309A (de)
NO (1) NO20023659L (de)
NZ (1) NZ520330A (de)
OA (1) OA12173A (de)
PL (1) PL357041A1 (de)
PT (1) PT1263421E (de)
SK (1) SK10972002A3 (de)
UA (1) UA75345C2 (de)
WO (1) WO2001056556A2 (de)
YU (1) YU57502A (de)
ZA (1) ZA200206075B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1281399A3 (de) * 2001-08-01 2004-02-11 Warner-Lambert Company Hemmer mit doppelter Wirkung auf Wachsester- und Cholesterylestersynthese zur Hemmung der Sebumproduktion
US20050031699A1 (en) 2003-06-26 2005-02-10 L'oreal Porous particles loaded with cosmetically or pharmaceutically active compounds
DK1673077T3 (da) 2003-10-09 2008-12-08 Warner Lambert Co Farmaceutiske præparater, der omfatter malonamidderivater til at nedsætte talgproduktion
MX2007010374A (es) 2005-02-24 2007-09-25 Warner Lambert Co Inhibidor de acat cristalino.
FR2904002A1 (fr) * 2006-07-19 2008-01-25 Galderma Res & Dev S N C Snc Modulateurs de la lanosterol synthetase dans le traitement de l'acne ou de l'hyperseborrhee
FR2903999B1 (fr) * 2006-07-19 2008-09-05 Galderma Res & Dev S N C Snc Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee
FR2938342A1 (fr) * 2008-11-13 2010-05-14 Galderma Res & Dev Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
WO2010087964A2 (en) 2009-01-28 2010-08-05 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
BR112020025208A2 (pt) * 2018-06-21 2021-03-09 Dermavant Sciences GmbH Formulações tópicas de inibidores de dgat1 e seus métodos de uso

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545977A (en) * 1985-01-11 1985-10-08 G. D. Searle & Co. Compositions and methods for treating severe acne with isotretinoin
US4751026A (en) 1986-03-24 1988-06-14 Warner-Lambert Company Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase
US4722927A (en) 1986-04-28 1988-02-02 Warner-Lambert Company Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase
JPS6323848A (ja) 1986-07-11 1988-02-01 ワ−ナ−−ランバ−ト・コンパニ− Ω−（置換フエニルオキシ）−アルカン酸のアリ−ル−およびアラルキルアミド
US4716175A (en) 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
IE61716B1 (en) 1987-06-02 1994-11-30 Warner Lambert Co Antihyperlipidemic and antiatherosclerotic urea compounds
US5015644A (en) 1987-06-02 1991-05-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
ATE61574T1 (de) 1987-07-02 1991-03-15 Warner Lambert Co N-((2,6-disubstituierte)-phenyl>-harnstoff und - carbamat-inhibitoren der acyl-coenzym a:cholesterol-acyltransferase.
US5030653A (en) 1988-03-30 1991-07-09 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4868210A (en) 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5116848A (en) 1988-03-30 1992-05-26 Warner-Lambert Company N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
US4999373A (en) 1988-03-30 1991-03-12 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4948806A (en) 1988-03-30 1990-08-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4923896A (en) 1989-02-09 1990-05-08 Warner-Lambert Company N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US5155127A (en) 1989-02-09 1992-10-13 Warner-Lambert Company N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US4994465A (en) 1989-02-17 1991-02-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds
AU632809B2 (en) 1989-05-25 1993-01-14 Takeda Chemical Industries Ltd. Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
AU629376B2 (en) 1989-08-04 1992-10-01 Mitsubishi Chemical Corporation 1-phenylalkyl-3-phenylurea derivatives
WO1991004027A1 (en) 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
TW205037B (de) 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd
JPH05310678A (ja) 1990-01-22 1993-11-22 Mitsubishi Kasei Corp １−フェニルアルキル−３−フェニル尿素誘導体
US5362878A (en) 1991-03-21 1994-11-08 Pfizer Inc. Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
ES2125325T3 (es) 1992-01-23 1999-03-01 Pfizer Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos.
AU4028393A (en) 1992-05-28 1993-12-30 Pfizer Inc. New (N)-aryl and (N)-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (ACAT)
US5565472A (en) 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5491172A (en) 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
US5596001A (en) 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
US5494172A (en) * 1994-05-12 1996-02-27 Miller Compressing Company Magnetic pulley assembly
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
WO1999067258A1 (en) * 1998-06-25 1999-12-29 Tularik Inc. Arylsulfonanilide phosphates
JP2004513090A (ja) * 2000-09-27 2004-04-30 メルク　エンド　カムパニー　インコーポレーテッド 糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体

Also Published As

Publication number Publication date
CA2398219A1 (en) 2001-08-09
IL150865A0 (en) 2003-02-12
EA200200764A1 (ru) 2002-12-26
SK10972002A3 (sk) 2003-07-01
ZA200206075B (en) 2003-10-30
ES2239145T3 (es) 2005-09-16
AP2002002612A0 (en) 2002-09-30
NO20023659D0 (no) 2002-08-01
YU57502A (sh) 2006-01-16
PT1263421E (pt) 2005-08-31
WO2001056556A3 (en) 2002-03-07
BG107042A (bg) 2003-04-30
NO20023659L (no) 2002-09-25
US6730703B2 (en) 2004-05-04
BR0107954A (pt) 2002-10-22
US20040161393A1 (en) 2004-08-19
CN1398182A (zh) 2003-02-19
EP1263421A2 (de) 2002-12-11
HUP0301010A2 (hu) 2003-08-28
NZ520330A (en) 2004-02-27
MXPA02007309A (es) 2002-11-29
ATE295724T1 (de) 2005-06-15
AU2971801A (en) 2001-08-14
CR6712A (es) 2004-01-14
KR20020073574A (ko) 2002-09-27
PL357041A1 (en) 2004-07-12
OA12173A (en) 2006-05-08
IS6478A (is) 2002-07-19
DE60110897T2 (de) 2006-03-23
DZ3288A1 (en) 2001-08-09
AU781563B2 (en) 2005-06-02
EE200200429A (et) 2003-12-15
HUP0301010A3 (en) 2005-03-29
MA26872A1 (fr) 2004-12-20
GEP20043286B (en) 2004-07-26
EA004255B1 (ru) 2004-02-26
JP2003531113A (ja) 2003-10-21
HRP20020717A2 (en) 2003-12-31
US20030060507A1 (en) 2003-03-27
EP1263421B1 (de) 2005-05-18
WO2001056556A2 (en) 2001-08-09
DE60110897D1 (de) 2005-06-23

Similar Documents

Publication Publication Date Title
AU757681B2 (en) Preventives/remedies for skin diseases
CA1337930C (en) Method of treating skin injuries using thromboxane a__ receptor antagonists
US6133326A (en) Compositions and methods for decreasing sebum production
JPH02295927A (ja) 尋常性座瘡を局所的に処置する方法
JPH07196497A (ja) アクネ又は脂漏症を阻止するのに適した医薬組成物
HUP0202548A2 (hu) Faggyútermelés gátlásánál alkalmazható viaszészter- és koleszterilészter-szintézist gátló kettős inhibitorok és ezeket tartalmazó gyógyszerkészítmények
EP1570850A1 (de) Topische Zusammensetzungen zur Behandlung von Rosacea
KR100864129B1 (ko) 여드름 치료를 위한 국소 답손
EP0784975B1 (de) Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen
UA75345C2 (en) Pharmaceutical composition for topical use intended for treating sebaceous gland disorders and methods of treating acnes using this composition
JPS5921630A (ja) 皮脂分泌低下剤
WO2009068876A1 (en) Compositions for the treatment of skin disorders
JPH0899889A (ja) アトピー性皮膚炎治療剤
JP7634814B2 (ja) 被膜形成能を有する高分子量セリシン組成物およびその製造方法
WO2025185660A1 (zh) 一种高载药量分子态辛伐他汀皮肤用软膏剂及其制备和应用
JPH0449216A (ja) メラニン抑制剤
EP1700597A1 (de) Pharmazeutische Zusammensetzung enthaltend in Assoziation Ubidecarenon, Dexpanthenol und Chlorhexidine oder eines seiner pharmazeutischen unbedenklichen Salze zur Anwendung auf der Haut